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Abstract: The blood–brain barrier (BBB) is a control mechanism that limits the diffusion of many substances to the central nervous
system (CNS). In this study, we designed an in-vitro 3-dimensional BBB system to obtain a fast and reliable model to mimic drug
delivery characteristics of the CNS. A support membrane of polycaprolactone nanofiber surfaces was prepared using electrospinning.
After confirming the fiber morphology and size, endothelial cells (HUVEC) and glial cells were cultured on either side of this membrane.
The model’s similarity to in vivo physiology was tested with a home-designed transmembrane resistance (TR) device, with positive
and negative control molecules. Finally, 2 doses of methotrexate (MTX), a chemotherapy agent, were applied to the model, and its
permeability through the model was determined indirectly by a vitality test on the MCF-7 cell line. Nicotine, the positive control,
completed its penetration through the model almost instantly, while albumin, the negative control, was blocked significantly even after
2 days. MTX reached a deadly threshold 24 h after application. The TR value of the model was promising, being around 260 ohm.cm2.
The provided model proposes a disposable and reliable tool for investigating drug permeability through the BBB and has the potential
to reduce the number of animal experiments.
Key words: Blood–brain barrier, electrospinning, methotrexate, 3-dimensional cell culture, transmembrane resistance

1. Introduction
The regulation of the nutrient balance in the human body
is strictly regulated, especially in the central nervous system
(CNS). Effective maintenance of the CNS is mediated by a
specific barrier, called the blood–brain barrier (BBB), which
restricts the permeability of some molecules, as well as
nutrients from the blood, to the CNS. Generally, lipophilic
and smaller molecules can pass through BBB, unlike larger
and lipid insoluble ones (Pardridge, 2007). This particularity
presents metabolical and physiological maintenance due to
selective transport, which provides an optimum medium
for neurons in the CNS (Huber et al., 2001).
On the other hand, the selectivity of the BBB may be
disadvantageous in clinics. The BBB constitutes a barrier
for a number of therapeutic interventions. Many drugs
have restricted penetration through the BBB, presenting
difficulty in reaching an effective concentration in the CNS
for the treatment of several neurological diseases (Deli
et al., 2005; Neuwelt et al., 2008). Hence, consideration

of the BBB as an obstacle to be overcome is crucial for
providing sufficient permeability and bioavailability of a
pharmaceutical in clinics.
The BBB includes several cellular elements, i.e.
endothelial cells, astrocytes, pericytes, and microglia
(Correale and Villa, 2009). Altogether, this cellular
structure exhibits unique characteristics and constitutes
a highly selective barrier. Specifically, the endothelial
cells in the BBB can produce complex and distinct tight
junctions compared to those in other tissues (Huber et
al., 2001) to regulate diffusivity, along with other cellular
elements. Transendothelial electrical resistance (TEER) is
a valuable parameter to show BBB effectiveness, as TEER
in CNS vasculature is higher than that in other parts of
the body (Patabendige et al., 2013; Wilhelm and Krizbai,
2014). Even though both pericytes and astrocytes have
major involvement in the BBB, the dominant mechanism is
thought to be tight junctions of endothelial cells (Burkhart
et al., 2015).
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To test the accuracy of drug delivery to the CNS,
reproducibility is essential to reliably investigate the effects
of different conditions in identical systems. Therefore,
many useful in vitro models have been designed (Zhang
et al., 2011; Bischel et al., 2016; Qi et al., 2018). The most
realistic in vitro models are the ones that mimic the in vivo
anatomical conditions properly by including almost all
cellular elements or their equivalents (Wilhelm and Krizbai,
2014). These models provide a controlled environment
for investigating the effects of treatment on the BBB in a
reproducible manner, and are useful for investigating the
penetration mechanism of novel therapeutics to the CNS
(Abbruscato et al., 2002).
In this study, we designed an in vitro BBB model using
an electrospun nanofibrous sheet mimicking the basement
membrane of CNS capillaries and a coculture of 2 cell lines,
human umbilical vein endothelial cells (HUVEC) and C6
glial cells, to imitate brain endothelial cells and astrocytes,
respectively. We, therefore, hypothesize that such a model
would mimic the natural metabolic BBB, where transport
of certain molecules across the model is blocked or
attenuated. The similarity of the model to in vivo BBB
and coculture functionality was investigated by measuring
transmembrane resistance (TR) and investigating the
diffusion of 2 model molecules, nicotine and bovine serum
albumin (BSA), through the coculture system. Finally,
the permeability of a common chemotherapy drug,
methotrexate (MTX), was tested by analyzing its effect on
the cell vitality of the human breast cancer cell line MCF-7.
2. Experimental procedure
2.1. Cell culture, test molecule applications, and reagents
C6 glial cells (gift from Ege University Hospital, Prof.
Dr. Gülperi Öktem) and HUVECs (from Ege University
Bioengineering Department, Biomaterials and 3D
Biointerphases Laboratory stocks) were cultured in
DMEM (Thermo Fisher Scientific Inc., Waltham, MA,
USA) consisting of 4.5 g/L glucose + 10% fetal bovine
serum (FBS) (Biochrome-AG, Berlin, Germany) + 0.1%
gentamicin (50 mg/mL) (Thermo Fisher Scientific Inc.).
For MCF-7 cells, DMEM/F12 consisting of 4.5 g/L glucose
+ 10% FBS + 0.1% gentamicin was used. The media were
changed 2 times a week in a Class II biosafety cabinet
(Esco Technologies, Inc., Horsham, PA, USA). All cell
types were kept in an incubator (Thermo Fisher Scientific
Inc.) at 37 °C and 5% CO2. Before subculturing the C6 glial
(1:3) and MCF-7 (1:3) cells, they were detached using 0.25
wt% Trypsin 0.53 mM EDTA (HyClone Laboratories Inc.,
Logan, UT, USA), while HUVECs (1:2) were scraped to
minimize disruption of cellular tight-junction proteins.
12 wt% polycaprolactone (PCL) solution was used
for electrospinning, as it had already been optimized in a
previous study in our lab (Zeybek et al., 2014). Next, 10
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mL N-N dimethylformamide (Sigma-Aldrich Corp., St.
Louis, MO, USA), 10 mL dichloromethane (Sigma-Aldrich
Corp.), and 2.4 grams of polycaprolactone (Sigma-Aldrich
Corp.) were mixed using MSH-20A magnetic stirrer
(WiseStir Limited, Bradford, UK).
Nicotine (positive control) permeability was
determined by taking advantage of the color change in
the chemical reaction of nicotine (from university stock)
and potassium permanganate (KMnO4) (from university
stock). This analysis had already been optimized in the
Ege University Bioengineering Department, and the
most efficient reaction was found with a mixture of 200
μL nicotine solution, 75 μL of KMnO4 (0.0125 M), and
150 μL of NaOH (6.25 M), at 95 °C and 7 min of reaction
time. The working concentration of nicotine was decided
based on the work of Lockman et al. (2005) as 4.5 μg / mL.
Nicotine solution with this concentration was loaded on
the inside of the insert. Three samples of 200 μL medium
from both sides of the inserts were taken after 2 and 48
h separately and mixed with 75 μL of KMnO4 and then
with 150 μL of NaOH (Sigma-Aldrich Corp.). Before the
spectrophotometric analysis, mixtures were heated to 95
°C in a plate heater for 7 min for the optimum reaction.
The purple color of KMnO4 turned greenish. The samples
were read with a spectrophotometer (Spectramax190;
Molecular Devices, San Jose, CA, USA) at 610 nm; the
amount of nicotine in terms of absorbance in either side of
the insert was compared.
Total BSA permeability was measured using the BCA
assay. BSA, a 60–70 kDa molecular weight protein that
cannot pass through the BBB, was used as a negative
control. We loaded 1.83 mg/mL BSA in distilled water
inside the inserts and took samples from each side of
the inserts 24 and 48 h after application. The samples
were diluted according to the BCA assay kit’s (SigmaAldrich Corp.) instructions. Five 0.75-μL samples from
the medium, with 3 repeats, were taken from each side of
the inserts. The samples were diluted by adding 149.25 μL
distilled water. For each 150 μL of diluted sample, 150 μL
of reaction mixture (73.5 μL reagent A, 73.5 μL Reagent
B, 3 μL copper solution) was added; and the mixture was
kept in a dark incubator (37 °C) for 2 h. The mixtures were
then analyzed in a spectrophotometer (Spectramax190,
Molecular Devices Corp., Sunnyvale, CA,USA) at 562 nm.
A common chemotherapeutic agent, MTX (a kind gift
from Ege University Hospital, Prof. Dr. Ayfer Haydaroğlu;
0.25%), was applied in 2 doses, 1 µg/0.5 mL and 5 µg/0.5
mL, directly inside the inserts after diluting in DMEM/
F12, and compared with the control where no drug had
been added.
2.2. PCL electrospinning
The PCL solution was drawn into a 21G-needle syringe and
placed in a homemade electrospinning setup consisting of
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an NE-1000 slow rate pump (New Era Pump Systems Inc.,
Farmingdale, NY, USA) and a voltage source (Inovenso
Inc., Woburn, MA, USA). An aluminum-foil–covered
tray was placed perpendicular to the syringe with 15 cm
distance. The voltage of 15.7 kV was applied between the
tip of the syringe and the tray, while the pump extruded
the PCL solution with a working flow rate of 1 mL/h.
2.3. Insert design
Once the electrospinning process had finished, electrospun
PCL fibers were collected from the aluminum foil and cut
into 2-cm diameter circles. These fiber circles were attached
to cylindrical inserts (Greiner, catalog no: 665640, Greiner
Bio-One GmbH, Kremsmünster, Austria), after removal of
their own PET membrane, using silicone O-rings. Active
seeding diameter was 0.6 cm (around 1.1 cm2 surface
area). Scaffolds were sterilized using ethylene oxide gas for
3 h and aerated for 12 h. The inserts with electrospun PCL
membranes attached were placed into 12-well plates with
sterile forceps and the inserts were coated with 2 wt% Type
B gelatin (Sigma-Aldrich Corp.) solution to improve cell
attachment.
To mimic the BBB, we seeded cells on either side of
the insert on PCL nanofiber membranes. HUVECs were
seeded onto the inside part of the membrane, which
represented the blood (luminal) side, while C6 glial cells
were seeded onto the outside part of the membrane, which
represented the brain (abluminal) side. Finally, MCF7 cells were seeded on the bottom surface of the 12-well
plate, and TR was measured.
2.4. Characterization of PCL scaffolds
To determine the mechanical properties of PCL scaffolds,
a uniaxial tensile test (DMA, Q800, TA Instruments, New
Castle, DE, USA) was performed in tension mode. PCL
scaffolds were cut to 5 × 5 × 0.07 mm (length × width ×
thickness) and mounted between tension clamps on the
device. Tests were performed at 0.1 N/min ramp force
to 18 N and 23 °C (N = 3) (Lobo et al., 2018). Young’s
modulus values were calculated by the slope of the stress–
strain curve in the linear region.
The PCL and the gelatin-coated PCL nanofibers were
characterized with an FT-IR spectrometer (Spectrum Two
FT-IR Spectrometer, PerkinElmer Corp., Waltham, MA,
USA). The spectrum of the scaffolds was recorded in the
spectral range, 4000–600 cm−1, at a resolution of 0.5 cm–1.
The PCL scaffolds were also characterized by scanning
electron microscopy (SEM) in order to observe nanofiber
structure.
2.5. Observation of cell morphology
To observe the morphology of both C6 and HUVECs
with SEM, cells were prefixed with glutaraldehyde (2.5%)
in 0.1 M sodium cacodylate buffer for 30 min at 4 °C
after washing with isotonic salt solution (pH 7.4). After
a treatment of 0.1 M sucrose in sodium cacodylate buffer

for 30 min, cells were postfixed with 1.0% OsO4 in 1.0
M sodium cacodylate buffer for 30 min. The cells were
dehydrated in an ethanol series (35%, 50%, 70%, 85%,
96%, and 100%) after washing 3× in ddH2O for 5 min. The
cells were held in a hexamethyldisilazane (HDMS, SigmaAldrich Corp.) solution for the chemical drying process
for 5 min and kept in the fume hood until completely dry.
The specimens were sputter-coated with approximately 6
nm of Au before the SEM observation.
2.6. Transmembrane resistance measurement
TR was measured using an LCR Meter (GW Instek,
Taipei, Taiwan) with a 12-Hz rate through the inside and
outside of the insert. The resistances were calculated by
multiplying the resistance value with the surface area of the
membranes (1.1 cm2) (Zhang et al., 2011). TR values were
then normalized by subtracting the medium resistance
from the obtained values.
2.7. Cellular viability test after MTX application
To test the permeability of our model to MTX, we indirectly
measured the viability of MCF-7 cells outside the inserts
by the MTT assay. 5 mg/mL MTT (Sigma-Aldrich) main
stock was diluted 10-fold in serum-free medium. The color
change was measured after 3 h of incubation in the dark
in an incubator at 37 °C and 5% CO2. Formazan crystals
were dissolved in dimethyl sulfoxide (Sigma-Aldrich
Corp.) by adding 1 mL to each well and shaken for 5 min
at room temperature in the dark. The absorbance was
measured at 570 nm and 690 nm. The difference between
the wavelengths was calculated to report net absorbance as
the sign of cell viability.
2.8. Statistical analysis
One-way ANOVA was used to test the different conditions
in TR measurements, and penetration of control molecules
in various time points. MTX groups, on the other hand,
were compared using two-way ANOVA between 2, 24,
and 48 h of application and 2 doses of drugs along with
controls. Multiple comparisons were made using Tukey’s
test for one-way ANOVA and the Bonferroni test for twoway ANOVA. Prism 7 (GraphPad, GraphPad Software
Inc., San Diego, CA, USA) was used for statistical analyses.
The level of significance was selected as P < 0.05.
3. Results
After confirming the size and shape of the PCL nanofibers,
we attached the membranes onto cell culture inserts
and seeded the cells on either side of the membranes.
To confirm the accuracy of the model, we measured TR
between the inside and outside of the model. Further, we
tested the permeability of positive (nicotine) and negative
(BSA) controls to reveal the diffusion characteristics of the
model. As the final step, we applied MTX and investigated
its toxic effect on the cells and permeability through the
model.
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3.1. Glial cells and HUVECs were seeded on both sides of
the static model of BBB
C6 glial cells were seeded on the outside surface of the
insert in a suspension of 200 μL DMEM (4.5 g/L glucose,
10% FBS, 0.1% gentamicin) with a concentration of 4
× 104 cells/insert and incubated for a day. After 24 h of
C6 glial cell culturing on the outside surface, HUVECs
were seeded on the inside surface of the insert in 700 μL
DMEM (4.5 g/L glucose, 10% FBS, 0.1% gentamicin) with
a concentration of 1 × 105 HUVECs/insert and incubated
for a day. MCF-7 cells were then seeded on the surface of
the 12-well plates in 1 mL DMEM (4.5 g/L glucose, 10%
FBS, 0.1% gentamicin) with a concentration of 1 × 104 cells
per well. Cellular morphology just after passage is shown
in Figures 1A–1C.
A polystyrene plate was bored with preheated silver
rods as electrodes. These electrodes were then glued to
the polystyrene plate using cyanoacrylate. One electrode
was placed inside the medium within the insert; the other
electrode was placed outside, between the insert and the
well plate (Figure 2).
3.2. PCL scaffold was suitable to retain cellular adhesion
Electrospun PCL nanofiber morphology was visualized
using SEM. Fiber diameter was between 194.5 and 840.3
nm (339.7 ± 144.4 nm) (Figures 3A–3D). The fibrous sheet
thickness of each membrane was less than 100 μm.
Young’s modulus values of the PCL scaffolds were
calculated by the slope of stress–strain curve in the linear
region. Stress and strain values at break were 2.128 (±0.439)
and 267.73 (±17.207), respectively. Young’s modulus value
with standard deviation (SD) of 3 PLC scaffolds was 0.609
(±0.056) MPa.
The FT-IR spectra of PCL nanofibers and dried
gelatin-coated PCL nanofibers are shown in Figure 4. The
characteristic functional group bands of PCL at 2945 cm−1
(asymmetric CH2 stretching), 2866 cm−1 (symmetric CH2
stretching), 1723 cm−1 (ester carbonyl stretching), 1294
cm−1 (vibration of C=O and C–C stretching), and 1239
cm−1 (asymmetric C–O–C stretching) were observed

on both FT-IR spectra (Kuppan et al., 2013; Jia et al.,
2016). On the gelatin-coated PCL nanofiber’s spectrum,
the characteristic protein bands were present, which are
attributed to amide I at 1652 cm−1 and amide II at 1542
cm−1, along with characteristic bands due to the PCL
(Kuppan et al., 2013; Pazhanimala et al., 2019). Moreover,
previous characterization of the PCL membrane using the
same production parameters in the lab showed around
136° water contact angle (Zeybek et al., 2014).
3.3. Glial cells and HUVECs represented normal cellular
morphology and confluency on PCL nanofibers
SEM images of the C6 seeded on the abluminal side and
HUVECs seeded on the luminal side of the gelatin-coated
PCL scaffold are given in Figure 5. At low magnification,
it can be clearly seen that HUVECs are more confluent
than C6 cells, as expected (Figures 5A and 5D). At high
magnification of SEM images, it was observed that the
C6 cells had heterogeneous protoplasmic astrocyte
morphology with many fine processes (Figures 5A–5C);
HUVECs had characteristic endothelial cobblestone
morphology and were in close contact with each other
(Figures 5D–5F).
3.4. Transmembrane resistance was the highest when
both cells were seeded
We compared TR between several conditions: i) PCL
membrane; ii) HUVEC-seeded membrane; iii) glial cellseeded membrane; and iv) membrane with both cells,
separately (Figure 6). No significant differences were
found between the membrane-only condition or HUVECor glial cell-seeded membrane condition; all were around
60–90 ohm.cm2 (P > 0.05). However, both cell-seeded
membranes had a TR of 263.53 ohm.cm2, which was
significantly higher than all other conditions ( membrane
only P = 0.0034, membrane + C6 P = 0.0052, membrane +
HUVEC P = 0.0083).
3.5. Nicotine penetrated the model whereas BSA was
effectively arrested
To test the selective permeability of our model, 2 molecules,
nicotine and BSA, were loaded inside the inserts having

Figure 1. Cellular morphology with 20x magnification is presented on tissue culture plate. A) Glial cells B) HUVEC C) MCF-7.
Scale bar is 50 μm.
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Figure 2. The model insert and TR measurements are illustrated. Using LCR meter, TR was
measured between “inside” and “outside” of the insert.

Figure 3. SEM image of electrospun PCL fibers with A) 25000 ×, B) 10000 ×, C) 5000 × and
D) 1000 × magnification, without cells seeded. Scale bars are shown on the figures.

HUVEC and C6 glial cells seeded on the membrane.
The penetration of the molecules was investigated using
spectrophotometric analysis (Figure 7). Nicotine solution
of 4.5 μg/mL was applied. It was found that nicotine
passed through the model and reached a plateau 2 h after

application (Figure 7A). No notable change was found
between the inside and outside of the insert after 48 h (P
> 0.05).
For the negative control, 1.83 mg/mL BSA was added
inside the insert; the amount of the protein inside and
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Figure 4. FT-IR spectra of electrospun PCL and gelatin-coated PCL nanofibers
between 3000 cm−1 and 1000 cm−1, at a resolution of 0.5 cm-1.

Figure 5. SEM images of the abluminal which is “outside” (A - C) and luminal which is “inside” (D - F) of the gelatin-coated PCL
scaffolds. C6 cells on the outside (abluminal - brain) of the insert show heterogeneous protoplasmic astrocyte morphology with
many fine processes A) 1000 ×, B) 5000 × and C) 10000 × magnifications. HUVECs on the inside (luminal - blood) of the insert
are more confluent than C6 cells; and they show characteristic endothelial cobblestone morphology with close contact with each
other D) 1000 ×, E) 5000 × and F) 10000 × magnifications.

outside of the inserts was detected using the bicinchoninic
acid (BCA) assay. After 24 h of application, 75% of the BSA
was significantly hindered by the model (P = 0.0012). In
addition, almost two-thirds of the BSA was significantly
kept inside the insert even 48 h after application (P =
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0.0168). It is also noted that the penetrated BSA reached
a plateau 24 h after application, as no significant change
was observed inside (P > 0.05) or outside of the insert (P >
0.05) after this time point (Figure 7B). The BSA inside was
higher than outside at both time points.
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Figure 6. Normalized TR values for each condition. All the
resistances were measured using an LCR meter. Readings were
multiplied by the surface area of the membranes to standardize
the resistance values. Normalization includes subtraction of the
electrical resistance value of the cell culture medium from the TR
values of each condition. Error bars are the standard deviation. **
P < 0.01. Total of 24 measurements were performed.

3.6. High dose methotrexate was more lethal than lower
dose after 24 h
The lethal effect of MTX on cell viability, using 3-(4, 5–
dimethylthiazol–2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) assay, was investigated for 2 concentrations 24

and 48 h after application. We measured the vitality of the
MCF-7 cell line after application of the low dose (LD) (1
µg/0.5 mL concentration of MTX) and the high dose (HD)
(5 µg/0.5 mL concentration of MTX) inside the inserts
(Figure 8).
Although we observed similar viability of MCF-7 2
h after application of both doses, with control having no
drug added (all P > 0.05), we found that the HD drug
application was significantly more lethal than the LD after
24 h (P = 0.0106) and resulted in less viability than the
control to which no drug was added (P < 0.0001). Moreover,
the viability of MCF-7 after HD application was observed
to be reduced even more 48 h after application compared
to LD and control (P < 0.0001). Although similar viability
was observed 2 h after LD drug application compared to
control (P = 0.1927), there was significant reduction in
cellular survival after both 24 h (P = 0.0001) and 48 h (P
< 0.0001).
Both LD and HD (P < 0.0001) application significantly
reduced cellular viability timewise between 2, 24, and 48 h.
4. Discussion
Drug delivery methods have recently been optimized to
target the CNS; however, the BBB is a significant obstacle,
as it restricts the diffusivity of the active molecule(s) from
the blood. To reach a therapeutic concentration in the CNS,
a molecule must pass this physiological barrier. Therefore,
we designed a 3-dimensional (3D) experimental model of
the BBB and tested its efficacy using control molecules,
measuring TR of the model and lethal effect of a common
chemotherapy drug. All of these trials were performed
in different samples to prevent additional effects, such as

Figure 7. Penetration properties of control molecules that applied inside the model. A) For the positive control, nicotine was introduced
inside the insert and samples were taken from both sides of the insert after 2 and 48 h of application. The absorbance of the nicotine
is shown in the figure. There is no significant difference between the nicotine concentration inside and outside the insert. B) As the
negative control, BSA was used in the same way as in the nicotine application. Samples were taken after 24 and 48 h of BSA application
from both sides of the insert and its absorbance were measured. BSA diffusion through the BBB model was significantly hindered on
both time points. Error bars are the standard deviation. ns P > 0.05, * P < 0.05, ** P < 0.01, N = 12 for both nicotine and BSA.
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nicotine’s alteration of the BBB’s permeability (Lockman
et al., 2005). Here, we discuss these original findings from
this study: the effect of cell selection, measurement, and
significance of the positive and negative controls, obtained
TR values, and MTX diffusivity to determine the overall
efficacy of the model.
4.1. Cellular composition of the proposed model
The components of the model were the cell lines used
to produce the 3D structure, along with electrospun
PCL nanofibers. An accurate selection of the cells is
indispensable for an appropriate model to mimic the
properties of the BBB in vivo. Endothelial cells of the
brain create a unique cellular structure of tight junctions
that cause high selectivity (Joó, 1996). Although specific
endothelial cell lines or primary cultures derived from
the brain capillaries are the best choices, HUVECs have
also been shown to be a good option due to their growth
kinetics (Kalashnik et al., 2000), and have been used in
various BBB models as a reliable cellular component (Yeon
et al., 2012). HUVECs are easy to cultivate, proliferate fast,
and create cellular junctions similar to tight junctions of in
vivo endothelial cells (Pawlowski NA, 1988). In addition,
it has been shown that nonneuronal endothelial cells, such
as HUVEC in our study, are capable of being induced to
have various blood–brain barrier properties via astrocytes
(Akiyama et al., 2000). In the aspect of astrocytes, C6 glial
cells have also been used for BBB studies (Raub, 1996);
they were selected as they proliferate fast, improving the
reproducibility of the model, and produce extracellular
matrix (Malek-Hedayat and Rome, 1992), providing
potential to increase the molecular selectivity. On the
other hand, MCF-7 cells do not belong to the CNS;
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however, clinically, symptomatic metastasis to the CNS
can be observed in patients with metastatic breast cancer
(Weil et al., 2005). MCF-7 was selected to represent a tumor
tissue since their properties are well defined in the literature,
including their growth kinetics as well as the existence of
receptors like estrogen and progesterone receptors (Brooks
et al., 1973).
4.2. Nicotine and BSA permeability of the model
Nicotine was used as a positive control due to its widely
known ability to pass the BBB (Lockman et al., 2005).
Animal behavioral studies that have investigated the brain
uptake rate of nicotine have revealed that exposure of 4.5 mg
nicotine solution/day resulted in consumption of 4.5 μg/mL
nicotine hourly (Lockman et al., 2005). We applied similar
doses of nicotine to our in vitro model and found that it
fully penetrated through the BBB and reached equilibrium
in only 2 h.
Due to its high molecular weight, BSA was used to
detect the blocking capacity of the model. It was shown that
the permeability of BSA is limited through BBB in both in
vivo (Shimon-Hophy et al., 1991) and in vitro (Smith and
Borchardt, 1989) models. We used the serum-free medium to
increase the precision of BCA analysis, as BSA in the serum
might affect the findings. However, cell-origin proteins,
cellular consumption of BSA, and heat-induced degradation
of BSA might affect the amount of protein detected, even
though heat degradation of BSA is unlikely at 37 °C (Borzova
et al., 2016). In order to minimize those effects, we analyzed
all of the inserts in the same environmental conditions and
then compared the total amount of proteins inside and
outside of the inserts, and assumed that the majority of the
detected protein was BSA. We found significant blocking of
the protein, as almost 75% of the molecule was kept inside
the insert even after one day of BSA application. Similarly,
almost 65% of the BSA was still located inside the insert at
the end of the second day, even though the total amount of
protein was lower compared to the first day, probably due to
cellular consumption.
4.3. MTX analysis to test drug retention of the model
To investigate the accuracy of the model, MTX was
applied to further prove the blocking properties. The doses
applied were 5 µg/0.5 mL and 1 µg/0.5 mL. We chose
these concentrations according to the studies that involve
intravenous and intraventricular injections in vivo (Shapiro
et al., 1975). MTT analysis showed that our model could
not block the MTX penetration for sustained exposure
if it lasted more than 24 h. The reduction in cell viability
outside the insert was lower as time passed, which shows
remarkable penetration. This could be because MTX
might first disrupt the model’s cellular elements since it is
highly toxic, especially for HUVECs, as they are the first
cells encountering the MTX. Eventually, MTX reaches the
bottom of the plate, where MCF-7 cells are located.
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When most of the drugs are applied intravenously, a
relatively lower concentration reaches the brain; the BBB
is the main mechanism that limits the effective transfer of
the drug to the CNS (Mangas-Sanjuan et al., 2010). Here,
we investigated the model’s accuracy according to the
effective concentration reached around the brain (outside
of the insert) and demonstrated that MTX disrupts the
cellular component of the model while passing through
the BBB (inside of the insert). However, MTX conjugated
nanoparticles increase the efficacy of targeting and reduces
the collateral damage to the healthy cells (Kohler et al.,
2005). This system might be applied to our model and
further proves that the reduction in cellular death in the
BBB model can improve the MTX retention inside the
inserts to show the reliability of this 3D coculture system.
4.4. Comparison of the model with the currently available
systems
We presented an improved 3D coculture model of the BBB
to be used in CNS toxicity and drug discovery studies.
We tested control substances that were either known to
be blocked by or pass through the BBB. Additionally, we
investigated if TR obtained from the model was close to
TEER values of in vivo and other in vitro BBB models.
More importantly, SEM images showed efficient cellular
attachment on either side of the scaffold.
The main advantage of the proposed model is swift
production of the scaffold material, fast/efficient testing of
the new substances due to easy production of the model,
and its low cost. Some similar studies use various primary
cells, such as neonatal rat glial cells (Gaillard et al., 2001;
Abbott et al., 2012). However, these systems need isolation,
characterization, and optimization of each cell batch when
obtained from animals, and may result in unpreventable
contamination of the other cellular elements. This, in
turn, may result in some variations in the produced in
vitro BBB and demands testing/characterization before
each use. Moreover, commercially available inserts, such
as polycarbonate cell culture inserts, have uniform pore
sizes but are more limited in mimicking in vivo conditions
as well as already lower membrane-only TEER than our
model used in this study (Eigenmann et al., 2013; Wuest
et al., 2013).
The current system is an example of a static model, which
does not effectively represent actual dynamic conditions
given that in vivo conditions include but are not limited
to continuous vascular flow and variabilities in blood
pressure. Dynamic BBB models propose more complex
systems and propose to mimic the in vivo environment
better compared to static models, as the dynamic models
include vascular flow as well as related extracellular matrix
and cellular components (Neuhaus et al., 2006; Cucullo et
al., 2011). In addition, these dynamic systems aim to mimic
the actual environment in vivo by providing a microfluidic

environment replicating multicellular mechanics and
architecture which is not comparable with the static models
(Xu et al., 2016). However, what we propose in this study
would be a first step in investigating the penetration of
drugs and molecules with low cost and in a faster manner
than dynamic systems, allowing an increased number of
trials in a short time with decent proximity.
Although the control substances had similar
penetration kinetics as we hypothesized, the TR value
of our model measured by LCR meter was about 30% of
the TEER value of the BBB model in Patabendige et al.
(2013). The TR value of our model (260 ohm.cm2) was
within the TEER values of the other cell culture models
that have previously been reported between 200–800 ohm.
cm2 (Abbott et al., 2012; Xue et al., 2013; Qi et al., 2018).
However, a value of around 1900 ohm.cm2 has been found
in vivo in the brain microvascular endothelium (Crone
and Olesen, 1982), which is another disadvantage of the
proposed model. Despite the lower TR value of the current
model compared to the natural BBB, other characteristics
of the model represent the physiological conditions of the in
vivo BBB. The TR value can be increased by implementing
dynamic flow conditions, which alone does not always
provide the necessary physiological conditions to mimic
the natural BBB (Cucullo et al., 2008; Appelt-Menzel et
al., 2017). The current static model, on the other hand,
provides instant nicotine penetration, which is compatible
with in vivo dynamic conditions (Lockman et al., 2005).
Additionally, albumin penetration in vivo was observed
to be very slow (Banks et al., 2000), which is sufficiently
demonstrated by our model, which kept two-thirds of the
BSA inside the insert even after 48 h. Moreover, the in
vitro models having resistance values above 150 ohm.cm2
are regarded as sufficient in contemporary pharmaceutical
research, that value is well below than the model presented
in this study (Appelt-Menzel et al., 2017).
The factors affecting the TR resistance in the BBB
models include cellular confluence on either side of the
membrane and their cell–cell junctions, porosity and
thickness of the nanofibers, types of cells seeded, initial
number of cells seeded, temperature, shear stress, and
ionic composition of the medium (Srinivasan et al., 2015).
Increased cell confluence, higher cellular contact, higher
initial seeded cell number, and a thicker membrane could
increase the resistance of the model, whereas higher
conductance ionic composition of the medium, higher
porosity, and selection of the cells (e.g., cells lacking tight
junction properties) could result in lower TR. In vivo
BBB has optimum blood ionic concentration, cellular
and basal lamina structure. These parameters could only
be provided by our model up to some extent, and this
causes a significant difference of TR between our model
and in vivo BBB. Therefore, this model can be improved by
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further optimization to be used as the first step in clinical
drug trials to test BBB permeability.
Another issue of the model to be considered before
application is the variability/randomness of the nanofiber
diameters that may result in slight deviations in the cellular
attachment. Randomly aligned nanofibers and cellular
contacts on either side increase the proximity of the
proposed model and mimic the natural BBB better. Having
appropriate basal membrane is crucial for mimicking
physiological homeostasis and allowing cellular contact.
Seeded cells on randomly aligned nanofibers tight enough
to retain cells allow cellular connections laterally, which
may allow tight junction formation on the luminal side and
perineuronal nets, as well as neural interstitial matrix on
the abluminal side. PCL nanofiber scaffolds with current
parameters are shown to support cellular attachment (TR
results) “and can accommodate different cell types than used
in this study (Zeybek et al., 2014). Changing parameters to
produce PCL nanofibers may affect structure and therefore
functional outcome. Several parameters, namely source to
ground distance and concentration of PCL solution, may
change pore size and nanofiber diameters as well as tensile
strength. Elastic modulus, for instance, may change from
around 4 MPa to levels of several tens of MPa by changing
the source to ground distance as well as the rotation of the
base if included (Gaumer et al., 2009). Moreover, these
parameters also change fiber angle and pore size (Gaumer
et al., 2009). Altogether, increased pore sizes may reduce
cellular attachment, and uniform fiber production may
affect cell proliferation and migration.
To overcome these disadvantages and in order to
produce a more effective and proximate model to in
vivo BBB, the compactness of electrospun fibers should

be optimized further by using materials with higher
compatibility with endothelial and glial cells; e.g., collagen
could be used instead of PCL. Electrospun collagen helps
cells attach and proliferate easily (Chen et al., 2010), which
might further increase the number of tight junctions, as
well as the TR value. The initial concentration of seeded
cells on the electrospun PCL could be optimized further
for the increased confluency of C6 glial cells and HUVECs
that contribute to the resistance. We selected HUVECs and
C6 glial cells due to their ability to create tight junctions
(Pawlowski NA, 1988) and extracellular matrix production
(Gladson, 1999), respectively, both of which contribute to
molecular selectivity. Finally, a different source of cells,
such as primary BBB elements, may be used to optimize
the cellular physiology in the model, which could mimic
the in vivo BBB in a more accurate manner, but this
requires extensive characterization before each use, which
is a drawback.
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